However, during HF, reduced AMPK activity leads to decreased expression of PPAR-α and its downstream genes, limiting the heart's ability to use FA, further exacerbating energy supply deficiencies, ultimately leading to abnormal LD accumulation and lipotoxic damage, accelerating HF progression (102). The gene discussed is PRKAA2; the disease is hydrops fetalis.